A Retrospective Comparative Study of 2-Drug Oral and Intramuscular Cephalosporin Treatment Regimens for Pharyngeal Gonorrhea | Zendy

Lindley A. Barbee | Zendy; Roxanne P. Kerani | Zendy; Julia C. Dombrowski | Zendy; Olusegun O. Soge | Zendy; Matthew R. Golden | Zendy

Open Access

A Retrospective Comparative Study of 2-Drug Oral and Intramuscular Cephalosporin Treatment Regimens for Pharyngeal Gonorrhea

Author(s) -

Lindley A. Barbee,

Roxanne P. Kerani,

Julia C. Dombrowski,

Olusegun O. Soge,

Matthew R. Golden

Publication year - 2013

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cit084

Subject(s) - medicine , gonorrhea , azithromycin , ceftriaxone , cephalosporin , retrospective cohort study , relative risk , doxycycline , confidence interval , antibacterial agent , surgery , antibiotics , immunology , microbiology and biotechnology , biology , human immunodeficiency virus (hiv)

The Centers for Disease Control and Prevention guidelines for pharyngeal gonorrhea treatment recommend dual therapy with intramuscular ceftriaxone and either azithromycin or doxycycline. Few clinical data exist to support this recommendation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research